01 8Cresemba
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 154
2019 Revenue in Millions : 145
Growth (%) : 6
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 196
2020 Revenue in Millions : 153
Growth (%) : 38
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 213
2021 Revenue in Millions : 196
Growth (%) : 9
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 195
2022 Revenue in Millions : 155
Growth (%) : 26
Main Therapeutic Indication : Anti-Fungal
Currency : USD
2018 Revenue in Millions : 112
2017 Revenue in Millions : 73
Growth (%) : 54%
Main Therapeutic Indication : Anti-fungal
Currency : USD
2016 Revenue in Millions : 45
2015 Revenue in Millions : 14
Growth (%) : 214
Main Therapeutic Indication : Anti-fungal
Currency : USD
2017 Revenue in Millions : 77
2016 Revenue in Millions : 48
Growth (%) : 61
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 147
2018 Revenue in Millions : 113
Growth (%) : 30
LOOKING FOR A SUPPLIER?
